From End-of-Life Care to Improved Quality of Life and Better Prognosis by Using Vericiguat: A Case Report From Costa Rica

In this case report, we present the evolution of a heart failure with reduced ejection fraction (HFrEF) patient who was set to receive end-of-life care but demonstrated improvement following treatment with vericiguat in combination with foundational therapy. Vericiguat is a novel soluble guanylate c...

Descripción completa

Detalles Bibliográficos
Autores principales: Speranza-Sánchez, Mario, Zavaleta-Monestel, Esteban, Sancho-Zumbado, Sonia, Arguedas-Chacón, Sebastián, Quirós-Romero, Alonso
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292727/
https://www.ncbi.nlm.nih.gov/pubmed/37378118
http://dx.doi.org/10.7759/cureus.39570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292727/
https://www.ncbi.nlm.nih.gov/pubmed/37378118
http://dx.doi.org/10.7759/cureus.39570

Ejemplares similares